Welcome to our dedicated page for Moelis & Co SEC filings (Ticker: MC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Moelis & Company filings document financial results, governance matters and capital-structure disclosures for a NYSE-listed independent investment bank. Form 8-K reports include earnings releases, Regulation FD presentation updates, board appointments and related material-event disclosures tied to the firm’s advisory business.
Proxy materials cover annual meeting matters, director elections, board committee structure, independence determinations and director compensation. The filings also identify the company’s Class A common stock registered under Section 12(b) and traded on the New York Stock Exchange under the symbol MC.
Shropshire Kenneth reported acquisition or exercise transactions in this Form 4 filing.
Moelis & Co director Kenneth Shropshire reported equity awards in the form of restricted stock units, not open-market trades. On July 1, 2026, he received 1,700 "2026 Annual Restricted Stock Units" and 200 "2026 Elective Restricted Stock Units," each representing one share of Class A common stock.
The RSUs were granted based on an average share price of $64.68 over the five trading days ended June 30, 2026. The 2026 Annual RSUs vested on July 1, 2026 and are scheduled to settle within 60 days after July 1, 2028. The 2026 Elective RSUs vest in equal quarters through July 1, 2027, with settlement within 60 days after each vesting date, reflecting routine non-employee director compensation.
Moelis & Company reported the results of its 2026 Annual Meeting of Stockholders held on June 25, 2026. Stockholders elected seven directors to the board, with each nominee receiving more votes for than against. Support levels varied by director but all were approved with additional broker non-votes recorded.
Stockholders also approved, on a non-binding advisory basis, the compensation of the company’s named executive officers, with over 80 million votes cast in favor versus approximately 25 million against. In addition, they ratified Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026, with a large majority of votes cast in favor.
Barker Thorold reported acquisition or exercise transactions in this Form 4 filing.
Moelis & Co director Barker Thorold received a grant of 15.9600 2025 Annual Restricted Stock Units as equity compensation. Each RSU represents the right to receive one share of Class A Common Stock. These RSUs were issued as dividend equivalents on underlying Annual RSUs issued on July 14, 2025 and will vest at the same time as that underlying award.
After this grant, Thorold’s direct holdings reported in this filing total 1665.2500 shares/units of Moelis & Co Class A equity. The transaction reflects a stock-based award rather than an open-market purchase or sale.
Moelis & Co director Louise Mirrer reported awards of additional restricted stock units tied to prior grants rather than any open-market trades. On June 18, 2026, she acquired 16.7600 2025 Annual RSUs and 0.3800 and 12.3900 2024 Annual RSUs, all at a stated price of $0.00 per unit.
Each RSU represents the right to receive one share of Class A Common Stock. The 2024 and 2025 Annual RSUs were issued as dividend equivalents on underlying annual RSU awards and will vest on the same schedule as those underlying grants. These are compensation-related equity accruals, not purchases or sales in the market.
Shropshire Kenneth reported acquisition or exercise transactions in this Form 4 filing.
Moelis & Co director Kenneth Shropshire reported routine equity compensation changes involving Restricted Stock Units (RSUs). On June 18, 2026, he was awarded 0.52 2025 Elective RSUs, 17.55 2025 Annual RSUs, and 21.03 2024 Annual RSUs, all at a reported price of $0.0000 per unit.
Each RSU represents the right to receive one share of Class A Common Stock. The 2024 and 2025 Annual RSUs and 2025 Elective RSUs were issued as dividend equivalents on underlying RSUs and will vest at the same time as those underlying awards. Following these awards, his reported RSU holdings in the respective series increased to 54.09, 1,831.67, and 2,194.94 units.
Moelis & Co director Laila Worrell reported grants of additional restricted stock units (RSUs) that function as dividend equivalents on existing awards. On 2026-06-18, she acquired 4.6000 2025 Elective RSUs, 16.7600 2025 Annual RSUs, and 20.0800 2024 Annual RSUs at a stated price of $0.0000 per unit. Each RSU represents the right to receive one share of Class A Common Stock. Following these awards, her reported direct holdings in these RSU categories increased to 479.5000, 1748.4600, and 2095.4700 units, respectively. The footnotes clarify that the 2024 and 2025 Annual and Elective RSUs were issued as dividend equivalents and will vest concurrently with the underlying RSUs.
Cantor Eric reported acquisition or exercise transactions in this Form 4 filing.
Moelis & Co director and Vice Chairman Eric Cantor reported compensation-related equity awards rather than open-market trades. On 2026-06-18, he received several small grants of Restricted Stock Units (RSUs) tied to Moelis Class A common stock.
The awards include 2024 Long Term Incentive RSUs, 2024 Incentive RSUs, and additional 2023, 2022, and 2021 Incentive RSUs issued as dividend equivalents on his existing unvested RSU grants. Each RSU will settle in either shares or cash at Moelis & Co’s option, and the dividend equivalent RSUs vest on the same schedule as the underlying unvested RSUs. No shares were bought or sold in the market in this filing.
Moelis & Co General Counsel and Secretary Osamu R. Watanabe reported awards of additional restricted stock units tied to prior equity grants. On June 18, 2026, he acquired small amounts of 2021–2025 Incentive RSUs and 2025 Special Incentive RSUs as dividend equivalents on his unvested RSUs.
Each RSU represents the right to receive either one share of Moelis & Co Class A common stock or cash equal to its fair market value upon settlement. The dividend equivalent RSUs will vest on the same schedule as the underlying unvested Incentive RSUs from the 2021–2026 grant years.
Riehl Nick reported acquisition or exercise transactions in this Form 4 filing.
Moelis & Company Principal Accounting Officer Nick Riehl reported routine equity compensation activity, receiving several small grants of Restricted Stock Units (RSUs) on June 18, 2026. These include 2025 Special Incentive RSUs, 2025 Incentive RSUs, 2024 Long Term and Incentive RSUs, and 2023 Long Term Incentive RSUs.
Each RSU represents the right to receive either a share of Class A common stock or cash equal to its fair market value upon settlement. The footnotes explain that these RSUs were issued as dividend equivalents on previously granted, unvested incentive RSUs and will vest on the same schedule as those underlying awards. No open-market purchases or sales were reported.
Pilcher Ciafone Katherine reported acquisition or exercise transactions in this Form 4 filing.
Moelis & Company Chief Operating Officer Katherine Pilcher Ciafone received additional incentive RSUs tied to prior equity awards. On June 18, 2026, she was granted 39.150 2022 Incentive RSUs and 13.760 2021 Incentive RSUs as dividend equivalents on her unvested underlying RSUs. These dividend-equivalent RSUs will vest on the same schedule as the original awards, and each unit may settle in either Class A common stock or cash equal to the share’s fair market value at settlement.